Revision as of 15:56, 19 May 2011 editLouisajb (talk | contribs)Extended confirmed users4,402 edits added chembl id← Previous edit | Revision as of 07:39, 23 May 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[WikipNext edit → | ||
Line 1: | Line 1: | ||
{{Unreferenced stub|auto=yes|date=December 2009}} | {{Unreferenced stub|auto=yes|date=December 2009}} | ||
{{Drugbox | {{Drugbox | ||
| Verifiedfields = changed | |||
| verifiedrevid = 376126506 | | verifiedrevid = 376126506 | ||
| IUPAC_name = | | IUPAC_name = | ||
Line 10: | Line 11: | ||
| PubChem = 71388 | | PubChem = 71388 | ||
| DrugBank = | | DrugBank = | ||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 1201548 | | ChEMBL = 1201548 | ||
| chemical_formula = (C<sub>15</sub>H<sub>21</sub>O(C<sub>2</sub>H<sub>4</sub>O)<sub>m</sub>)<sub>n</sub> | | chemical_formula = (C<sub>15</sub>H<sub>21</sub>O(C<sub>2</sub>H<sub>4</sub>O)<sub>m</sub>)<sub>n</sub> |
Revision as of 07:39, 23 May 2011
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Tyloxapol" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message) |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.209.660 |
Chemical and physical data | |
Formula | (C15H21O(C2H4O)m)n |
Molar mass | variable |
(what is this?) (verify) |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins.
This drug article relating to the respiratory system is a stub. You can help Misplaced Pages by expanding it. |